Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
FDA record creation date
Mar 28, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III
Reason stated in the source
The firm issued an updated instructions for use to reduce the potential for phrenic nerve injury.
Source facts
Action
The firm initiated the communication on 03/04/2019 by letter. Consignees are asked to review the communication to understand that Medtronic is adding current recommendations for reducing the potential for PNI. The IFU will be updated globally, including completing submissions and obtaining regulatory approvals, where prior approvals are required. This event involves OUS consignees only.
Initiated
2019-03-04
Root cause
Labeling Change Control
Distribution
International distribution in the countries of Australia, Austria, Brazil, Canada, France, Germany, Hungary, Ireland, Israel, Italy, Latvia, Netherlands, Poland, Portugal, Spain, Switzerland, United Kingdom.
Recall number
Z-1069-2019
Recall status
Open, Classified
CDRH record ID
171345
FDA record created
2019-03-28
Recall event number
82319
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.